Study of the Impact of the COVID-19 Pandemic on the Management of Type 2 Diabetic Patients in a Sample in the Paris Region
CompletedOBSERVATIONAL
Enrollment
100
Participants
Timeline
Start Date
March 10, 2022
Primary Completion Date
December 31, 2022
Study Completion Date
February 2, 2023
Conditions
COVID-19Diabetes Mellitus, Type 2
Trial Locations (1)
75014
Groupe Hospitalier Paris Saint-Joseph, Paris
All Listed Sponsors
lead
Fondation Hôpital Saint-Joseph
OTHER
NCT05175677 - Study of the Impact of the COVID-19 Pandemic on the Management of Type 2 Diabetic Patients in a Sample in the Paris Region | Biotech Hunter | Biotech Hunter